Clinical trial

Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease

NCT02099903

Study summary

ClinicalTrials.gov

Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention transcatheter renal denervation Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-03-01

PhaseNA

Conditions

Heart Failureverified · MONDO: heart failure

Heart Failure, Systoliccandidate · MONDO: systolic heart failure

Chagas Diseaseverified · MONDO: Chagas disease

Chagas Cardiomyopathyverified · MONDO: Chagas cardiomyopathy

Interventions

transcatheter renal denervationDEVICE

Sponsors & collaborators

InCor Heart Institutelead sponsor

Johnson & Johnsoncollaborator

Mapped research locations

São PauloSão Paulo, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02099903 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.